Inhibition of B16 murine melanoma metastasis and enhancement of immunity by fever-range whole body hyperthermia

References

• Ito A, Matsuoka F, Honda H, Kobayashi T. Heat shock protein 70 gene therapy combined with hyperthermia using magnetic nanoparticles. Cancer Gene Therapy 2003; 10: 918–925
   PubMed Web of Science ®Google Scholar
• Von Ardenne A, Wehner H. Extreme whole-body hyperthermia with water-filtered infrared-A radiation. In: Baronzio GF, Hager ED, editors. Hyperthermia in cancer treatment: A primer. New York: Springer. 2006, pp. 237–246
   Google Scholar
• Grimm MJ, Zynda ER, Repasky EA. Temperature matters: Cellular targets of hyperthermia in cancer biology and immunology. In: Pockley AG, Calderwood SK, Santoro MG, editors. Prokaryotic and Eukaryotic Heat Shock Proteins in Infectious Disease. London New York: Springer, Dordrecht Heidelberg. 2009, pp. 267–306
   Google Scholar
• Atanackovic D, Nierhaus A, Neumeier M, Hossfeld D, Hegewisch-Becker S. 41.8°C whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseases. Cancer Immunol Immunother 2002; 51: 603–613
   PubMed Web of Science ®Google Scholar
• Jia D, Liu J. Current devices for high-performance whole-body hyperthermia therapy. Expert Rev Med Dev 2010; 7: 407–423
   PubMed Web of Science ®Google Scholar
• Shen R-N, Hornback NB, Shidnia H, Shupe RE, Brahmi Z. Whole-body hyperthermia decreases lung metastases in lung tumor-bearing mice, possibly via a mechanism involving natural killer cells. J Clin Immunol 1987; 7: 246–253
   PubMed Web of Science ®Google Scholar
• Barginear MF, Van Poznak C, Rosen N, Modi S, Hudis CA, Budman DR. The heat shock protein 90 chaperone complex: An evolving therapeutic target. Curr Cancer Drug Targets 2008; 8: 522–535
   PubMedGoogle Scholar
• Franckena M, Stalpers LJA, Koper PCM, Wiggenraad RGJ, Hoogenraad WJ, van Dijk JDP, Wárlám-Rodenhuis CC, Jobsen JJ, van Rhoon GC, van der Zee J. Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: An update of the Dutch Deep Hyperthermia Trial. International Journal of Radiation Oncology, Biology, Physics. 2008; 70: 1176–1182
   PubMed Web of Science ®Google Scholar
• Sreedhar AS, Csermely P. Heat shock proteins in the regulation of apoptosis: New strategies in tumor therapy: A comprehensive review. Pharmacol Ther 2004; 101: 227–257
   PubMed Web of Science ®Google Scholar
• Multhoff G. Activation of natural killer cells by heat shock protein 70. Int J Hyperthermia 2009; 25: 169–175
   PubMed Web of Science ®Google Scholar
• Ito A, Honda H, Kobayashi T. Cancer immunotherapy based on intracellular hyperthermia using magnetite nanoparticles: A novel concept of ‘heat-controlled necrosis’ with heat shock protein expression. Cancer Immunol Immunother 2006; 55: 320–328
   PubMed Web of Science ®Google Scholar
• Taylor A, Kraemer K, Hampel S, Fuessel S, Klingeler R, Ritschel M, Buechner B, Grimm MO, Wirth MP. Carbon coated nanomagnets as potential hyperthermia agents. J Urol 2008; 179: 392–393
   Google Scholar
• Li X, Huang M, Zheng H, Wang Y, Ren F, Shang Y, Zhai Y, Irwin DM, Shi Y, Chen D. CHIP promotes Runx2 degradation and negatively regulates osteoblast differentiation. J Cell Biol 2008; 181: 959–972
   PubMedGoogle Scholar
• Hoshino T, Matsuda M, Yamashita Y, Takehara M, Fukuya M, Mineda K, Maji D, Ihn H, Adachi H, Sobue G. Suppression of melanin production by expression of HSP70. J Biol Chem 2010; 282: 13254–13263
   Google Scholar
• Stojkovic R, Radacic M. Cell killing of melanoma B16 in vivo by hyperthermia and cytotoxins. Int J Hyperthermia 2002; 18: 62–71
   PubMed Web of Science ®Google Scholar
• Oguni A, Umeda M, Shigeta T, Takahashi H, Komori T. The influence of surgical procedure and the effect of chemotherapy on nodal and distant metastases of human malignant melanomas that have been grafted into nude mice. Int J Oral Maxillofac Surg 2010; 39: 42–49
   PubMedGoogle Scholar
• Millward MJ, Bedikian AY, Conry RM, Gore ME, Pehamberger HE, Sterry W, Pavlick AC, De Conti RC, Gordon D, Itri LM. Randomized multinational phase 3 trial of dacarbazine (DTIC) with or without Bcl-2 antisense (oblimersen sodium) in patients (pts) with advanced malignant melanoma (MM): Analysis of long-term survival. J Clin Oncol 2004; 22: 7505–7505
   Google Scholar
• Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004; 4: 71–78
   PubMed Web of Science ®Google Scholar
• Takakura N. Role of hematopoietic lineage cells as accessory components in blood vessel formation. Cancer Science 2006; 97: 568–574
   PubMedGoogle Scholar
• Noonan D, De Lerma Barbaro A, Vannini N, Mortara L, Albini A. Inflammation, inflammatory cells and angiogenesis: Decisions and indecisions. Cancer Metastasis Rev 2008; 27: 31–40
   PubMed Web of Science ®Google Scholar
• Steeg PS. Tumor metastasis: Mechanistic insights and clinical challenges. Nat Med 2006; 12: 895–904
   PubMed Web of Science ®Google Scholar
• Albini A, Sporn MB. The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer 2007; 7: 139–147
   PubMed Web of Science ®Google Scholar
• Litton MJ, Dohlsten M, Rosendahl A, Ohlsson L, Sgaard M, Andersson J, Andersson U. The distinct role of CD4+ and CD8+ T-cells during the anti-tumour effects of targeted superantigens. Br J Cancer 1999; 81: 359–366
   PubMed Web of Science ®Google Scholar
• Atanackovic D, Pollok K, Faltz C, Boeters I, Jung R, Nierhaus A, Braumann KM, Hossfeld DK, Hegewisch-Becker S. Patients with solid tumors treated with high-temperature whole body hyperthermia show a redistribution of naive/memory T-cell subtypes. Am J Physiol – Reg, Integ Comp Physiol 2006; 290: R585–R594
   PubMed Web of Science ®Google Scholar
• Chen Q, Fisher DT, Clancy KA, Gauguet JMM, Wang WC, Unger E, Rose-John S, von Andrian UH, Baumann H, Evans SS. Fever-range thermal stress promotes lymphocyte trafficking across high endothelial venules via an interleukin 6 trans-signaling mechanism. Nat Immunol 2006; 7: 1299–1308
   PubMed Web of Science ®Google Scholar
• Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001; 411: 342–348
   PubMed Web of Science ®Google Scholar
• Banerji U. Heat shock protein 90 as a drug target: Some like it hot. Clin Cancer Res 2009; 15: 9–14
   PubMed Web of Science ®Google Scholar
• Alao JP, Gamble SC, Stavropoulou AV, Pomeranz KM, Lam EW, Coombes RC, Vigushin DM. The cyclin D1 proto-oncogene is sequestered in the cytoplasm of mammalian cancer cell lines. Mol Cancer 2006; 5: 7
   PubMed Web of Science ®Google Scholar
• Caputi M, Groeger AM, Esposito V, Dean C, De Luca A, Pacilio C, Muller MR, Giordano GG, Baldi F, Wolner E. Prognostic role of cyclin D1 in lung cancer. Relationship to proliferating cell nuclear antigen. Am J Respir Cell Mol Biol 1999; 20: 746–750
   PubMedGoogle Scholar
• Pasco S, Ramont L, Venteo L, Pluot M, Maquart FX, Monboisse JC. In vivo overexpression of tumstatin domains by tumor cells inhibits their invasive properties in a mouse melanoma model. Exp Cell Res 2004; 301: 251–265
   PubMedGoogle Scholar
• Stellas D, Karameris A, Patsavoudi E. Monoclonal antibody 4C5 immunostains human melanomas and inhibits melanoma cell invasion and metastasis. Clin Cancer Res 2007; 13: 1831–1838
   PubMedGoogle Scholar
• Hall PA, Levison DA, Woods AL, Yu CCW, Kellock DB, Watkins JA, Barnes DM, Gillett CE, Camplejohn R, Dover R. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some, neoplasms. J Pathol 2005; 162: 285–294
   Google Scholar
• Jónsson ZO, Hübscher U. Proliferating cell nuclear antigen: More than a clamp for DNA polymerases. Bioessays 2005; 19: 967–975
   Google Scholar
• Kim SH, Kim Y, Kim M, Kim DS, Lee SC, Chi SW, Lee DH, Park SG, Park BC, Bae KH. Comparative proteomic analysis of mouse melanoma cell line B16, a metastatic descendant B16F10, and B16 overexpressing the metastasis-associated tyrosine phosphatase PRL-3. Oncology Research 2009; 17(11–12)601–612
   PubMedGoogle Scholar
• Stacey DW. Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells. Curr Opin Cell Biol 2003; 15: 158–163
   PubMed Web of Science ®Google Scholar
• Guo J, Zhu J, Sheng X, Wang X, Qu L, Han Y, Liu Y, Zhang H, Huo L, Zhang S, et al. Intratumoral injection of dendritic cells in combination with local hyperthermia induces systemic antitumor effect in patients with advanced melanoma. Int J Cancer 2007; 120: 2418–2425
   PubMed Web of Science ®Google Scholar
• Whiteside TL. The tumor microenvironment and its role in promoting tumor growth. Oncogene 2008; 27: 5904–5912
   PubMed Web of Science ®Google Scholar
• Ostrand-Rosenberg S, Sinha P. Myeloid-derived suppressor cells: Linking inflammation and cancer. J Immunol 2009; 182: 4499–4506
   PubMed Web of Science ®Google Scholar
• Cheng P, Corzo CA, Luetteke N, Yu B, Nagaraj S, Bui MM, Ortiz M, Nacken W, Sorg C, Vogl T, et al. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J Exp Med 2008; 205: 2235–2249
   PubMed Web of Science ®Google Scholar
• Chen T, Guo J, Han C, Yang M, Cao X. Heat shock protein 70, released from heat-stressed tumor cells, initiates antitumor immunity by inducing tumor cell chemokine production and activating dendritic cells via TLR4 pathway. J Immunol 2009; 182: 1449–1459
   PubMed Web of Science ®Google Scholar